Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
This report aims to provide a comprehensive presentation of the global market for Drugs for Malaria, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Malaria. This report contains market size and forecasts of Drugs for Malaria in global, including the following market information:
- Global Drugs for Malaria Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drugs for Malaria market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.
We surveyed the Drugs for Malaria companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Malaria Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Malaria Market Segment Percentages, by Type, 2022 (%)
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
Global Drugs for Malaria Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Malaria Market Segment Percentages, by Application, 2022 (%)
- Prevention
- Treatment
- Others
Global Drugs for Malaria Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drugs for Malaria Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Drugs for Malaria revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Drugs for Malaria revenues share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Drugs for Malaria, market overview.
- Chapter 2: Global Drugs for Malaria market size in revenue.
- Chapter 3: Detailed analysis of Drugs for Malaria company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Drugs for Malaria in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Malaria Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Malaria Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Malaria Overall Market Size
2.1 Global Drugs for Malaria Market Size: 2022 VS 2029
2.2 Global Drugs for Malaria Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Malaria Players in Global Market
3.2 Top Global Drugs for Malaria Companies Ranked by Revenue
3.3 Global Drugs for Malaria Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Malaria Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Malaria Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Malaria Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Malaria Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Malaria Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Malaria Market Size Markets, 2022 & 2029
4.1.2 Aryl Aminoalcohol Compounds
4.1.3 Antifolate Compounds
4.1.4 Artemisinin Compounds
4.2 By Type - Global Drugs for Malaria Revenue & Forecasts
4.2.1 By Type - Global Drugs for Malaria Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Malaria Revenue, 2024-2029
4.2.3 By Type - Global Drugs for Malaria Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Malaria Market Size, 2022 & 2029
5.1.2 Prevention
5.1.3 Treatment
5.1.4 Others
5.2 By Application - Global Drugs for Malaria Revenue & Forecasts
5.2.1 By Application - Global Drugs for Malaria Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Malaria Revenue, 2024-2029
5.2.3 By Application - Global Drugs for Malaria Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Drugs for Malaria Market Size, 2022 & 2029
6.2 By Region - Global Drugs for Malaria Revenue & Forecasts
6.2.1 By Region - Global Drugs for Malaria Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Malaria Revenue, 2024-2029
6.2.3 By Region - Global Drugs for Malaria Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Drugs for Malaria Revenue, 2018-2029
6.3.2 US Drugs for Malaria Market Size, 2018-2029
6.3.3 Canada Drugs for Malaria Market Size, 2018-2029
6.3.4 Mexico Drugs for Malaria Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Drugs for Malaria Revenue, 2018-2029
6.4.2 Germany Drugs for Malaria Market Size, 2018-2029
6.4.3 France Drugs for Malaria Market Size, 2018-2029
6.4.4 U.K. Drugs for Malaria Market Size, 2018-2029
6.4.5 Italy Drugs for Malaria Market Size, 2018-2029
6.4.6 Russia Drugs for Malaria Market Size, 2018-2029
6.4.7 Nordic Countries Drugs for Malaria Market Size, 2018-2029
6.4.8 Benelux Drugs for Malaria Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Drugs for Malaria Revenue, 2018-2029
6.5.2 China Drugs for Malaria Market Size, 2018-2029
6.5.3 Japan Drugs for Malaria Market Size, 2018-2029
6.5.4 South Korea Drugs for Malaria Market Size, 2018-2029
6.5.5 Southeast Asia Drugs for Malaria Market Size, 2018-2029
6.5.6 India Drugs for Malaria Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Drugs for Malaria Revenue, 2018-2029
6.6.2 Brazil Drugs for Malaria Market Size, 2018-2029
6.6.3 Argentina Drugs for Malaria Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Malaria Revenue, 2018-2029
6.7.2 Turkey Drugs for Malaria Market Size, 2018-2029
6.7.3 Israel Drugs for Malaria Market Size, 2018-2029
6.7.4 Saudi Arabia Drugs for Malaria Market Size, 2018-2029
6.7.5 UAE Drugs for Malaria Market Size, 2018-2029
7 Drugs for Malaria Companies Profiles
7.1 Cipla
7.1.1 Cipla Company Summary
7.1.2 Cipla Business Overview
7.1.3 Cipla Drugs for Malaria Major Product Offerings
7.1.4 Cipla Drugs for Malaria Revenue in Global Market (2018-2023)
7.1.5 Cipla Key News & Latest Developments
7.2 Guilin Pharmaceutical
7.2.1 Guilin Pharmaceutical Company Summary
7.2.2 Guilin Pharmaceutical Business Overview
7.2.3 Guilin Pharmaceutical Drugs for Malaria Major Product Offerings
7.2.4 Guilin Pharmaceutical Drugs for Malaria Revenue in Global Market (2018-2023)
7.2.5 Guilin Pharmaceutical Key News & Latest Developments
7.3 IPCA Laboratories
7.3.1 IPCA Laboratories Company Summary
7.3.2 IPCA Laboratories Business Overview
7.3.3 IPCA Laboratories Drugs for Malaria Major Product Offerings
7.3.4 IPCA Laboratories Drugs for Malaria Revenue in Global Market (2018-2023)
7.3.5 IPCA Laboratories Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Drugs for Malaria Major Product Offerings
7.4.4 GlaxoSmithKline Drugs for Malaria Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Mylan Labs
7.5.1 Mylan Labs Company Summary
7.5.2 Mylan Labs Business Overview
7.5.3 Mylan Labs Drugs for Malaria Major Product Offerings
7.5.4 Mylan Labs Drugs for Malaria Revenue in Global Market (2018-2023)
7.5.5 Mylan Labs Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Drugs for Malaria Major Product Offerings
7.6.4 Roche Drugs for Malaria Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Drugs for Malaria Major Product Offerings
7.7.4 Novartis Drugs for Malaria Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Sanofi Aventis
7.8.1 Sanofi Aventis Company Summary
7.8.2 Sanofi Aventis Business Overview
7.8.3 Sanofi Aventis Drugs for Malaria Major Product Offerings
7.8.4 Sanofi Aventis Drugs for Malaria Revenue in Global Market (2018-2023)
7.8.5 Sanofi Aventis Key News & Latest Developments
7.9 Ajanta Pharma
7.9.1 Ajanta Pharma Company Summary
7.9.2 Ajanta Pharma Business Overview
7.9.3 Ajanta Pharma Drugs for Malaria Major Product Offerings
7.9.4 Ajanta Pharma Drugs for Malaria Revenue in Global Market (2018-2023)
7.9.5 Ajanta Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Malaria Market Opportunities & Trends in Global Market
Table 2. Drugs for Malaria Market Drivers in Global Market
Table 3. Drugs for Malaria Market Restraints in Global Market
Table 4. Key Players of Drugs for Malaria in Global Market
Table 5. Top Drugs for Malaria Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs for Malaria Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs for Malaria Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs for Malaria Product Type
Table 9. List of Global Tier 1 Drugs for Malaria Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Malaria Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs for Malaria Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Drugs for Malaria Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs for Malaria Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Drugs for Malaria Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Drugs for Malaria Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs for Malaria Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Drugs for Malaria Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Drugs for Malaria Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs for Malaria Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Drugs for Malaria Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs for Malaria Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Drugs for Malaria Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs for Malaria Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Drugs for Malaria Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs for Malaria Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Drugs for Malaria Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs for Malaria Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Drugs for Malaria Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs for Malaria Revenue, (US$, Mn), 2024-2029
Table 30. Cipla Company Summary
Table 31. Cipla Drugs for Malaria Product Offerings
Table 32. Cipla Drugs for Malaria Revenue (US$, Mn) & (2018-2023)
Table 33. Cipla Key News & Latest Developments
Table 34. Guilin Pharmaceutical Company Summary
Table 35. Guilin Pharmaceutical Drugs for Malaria Product Offerings
Table 36. Guilin Pharmaceutical Drugs for Malaria Revenue (US$, Mn) & (2018-2023)
Table 37. Guilin Pharmaceutical Key News & Latest Developments
Table 38. IPCA Laboratories Company Summary
Table 39. IPCA Laboratories Drugs for Malaria Product Offerings
Table 40. IPCA Laboratories Drugs for Malaria Revenue (US$, Mn) & (2018-2023)
Table 41. IPCA Laboratories Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Drugs for Malaria Product Offerings
Table 44. GlaxoSmithKline Drugs for Malaria Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Mylan Labs Company Summary
Table 47. Mylan Labs Drugs for Malaria Product Offerings
Table 48. Mylan Labs Drugs for Malaria Revenue (US$, Mn) & (2018-2023)
Table 49. Mylan Labs Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Drugs for Malaria Product Offerings
Table 52. Roche Drugs for Malaria Revenue (US$, Mn) & (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Drugs for Malaria Product Offerings
Table 56. Novartis Drugs for Malaria Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Sanofi Aventis Company Summary
Table 59. Sanofi Aventis Drugs for Malaria Product Offerings
Table 60. Sanofi Aventis Drugs for Malaria Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Aventis Key News & Latest Developments
Table 62. Ajanta Pharma Company Summary
Table 63. Ajanta Pharma Drugs for Malaria Product Offerings
Table 64. Ajanta Pharma Drugs for Malaria Revenue (US$, Mn) & (2018-2023)
Table 65. Ajanta Pharma Key News & Latest Developments
List of Figures
Figure 1. Drugs for Malaria Segment by Type in 2022
Figure 2. Drugs for Malaria Segment by Application in 2022
Figure 3. Global Drugs for Malaria Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Malaria Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs for Malaria Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Malaria Revenue in 2022
Figure 8. By Type - Global Drugs for Malaria Revenue Market Share, 2018-2029
Figure 9. By Application - Global Drugs for Malaria Revenue Market Share, 2018-2029
Figure 10. By Type - Global Drugs for Malaria Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Drugs for Malaria Revenue Market Share, 2018-2029
Figure 12. By Application - Global Drugs for Malaria Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Drugs for Malaria Revenue Market Share, 2018-2029
Figure 14. By Region - Global Drugs for Malaria Revenue Market Share, 2018-2029
Figure 15. By Country - North America Drugs for Malaria Revenue Market Share, 2018-2029
Figure 16. US Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Drugs for Malaria Revenue Market Share, 2018-2029
Figure 20. Germany Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 21. France Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Drugs for Malaria Revenue Market Share, 2018-2029
Figure 28. China Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 32. India Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Drugs for Malaria Revenue Market Share, 2018-2029
Figure 34. Brazil Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Drugs for Malaria Revenue Market Share, 2018-2029
Figure 37. Turkey Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Drugs for Malaria Revenue, (US$, Mn), 2018-2029
Figure 41. Cipla Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Guilin Pharmaceutical Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. IPCA Laboratories Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Mylan Labs Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roche Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Aventis Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ajanta Pharma Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
